18-Crown-6-etherは,マルチドラッグエフフリュースポンプ EmrEによる輸送を分離するために,明確なアロステリック相互作用を使用します
Merissa Brousseau1, Tapasyatanu Dash2, Michael J Rourke3
1Biochemistry Department, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
Biochemistry
|September 3, 2025
まとめ
エシェリキア・コリ菌による多剤流出ポンプ EmrEは治療の標的となる. 18クラウン-6エーテルが リシン22に結合して 陽子漏れを引き起こし 輸送器の制御に 新たな洞察をもたらしました
科学分野:
- 生物化学
- 分子生物学
- 微生物学
背景:
- エシェリキア・コリ菌による多剤流出ポンプEmrEは,複数の輸送機能を示し,潜在的な治療標的を提示する.
- 小分子基板は,典型的な抗生物質耐性フェノタイプとは対照的に,トランスポーター依存の感受性を誘発することができる.
研究 の 目的:
- EmrEトランスポーターにおける小分子基板18-クラウン-6-エーターの結合部位と作用機構を調査する.
- EmrE輸送のアロステリック調節におけるライシン22とスレオニン56の役割を解明する.
主な方法:
- 核磁気共鳴 (NMR) の化学的シフト乱れを用いて,18-クラウン-6-エーテルの結合部位を特定した.
- トランスポーター活動と基板誘発効果を評価するために,in vivo EC50アッセイとリポソーマルリークアッセイを使用した.
主要な成果:
- EmrEトランスポーターのライシン22 (K22) に結合することが確認された.
- この基板は,正常な輸送規則の障害を示唆する,結合されていない陽子の漏れを誘発することが示されました.
- K22の変異分析は,この残留物とT56がアロステル調節における重要性をさらに固めた.
結論:
- リシン22は,特にC端尾との相互作用で,EmrEのアロステリック調節のための重要な残留物です.
- EmrEの輸送機構と受容性基板による制御を理解することで,他の多剤耐性流出ポンプに適用できる洞察が得られます.
さらに関連する動画
09:12Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane SSM-Based Electrophysiology
Published on: May 3, 2021
2.7K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
721
関連する概念動画
01:06Carrier-Mediated Transport
541
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
541
01:17Pore Transport and Ion-Pair Transport
635
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
635
01:31ABC Transporters: Exporter
4.9K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.9K
02:36Crown Ethers
5.4K
Crown ethers are cyclic polyethers that contain multiple oxygen atoms, usually arranged in a regular pattern. The first crown ether was synthesized by Charles Pederson while working at DuPont in 1967. For this work, Pedersen was co-awarded the 1987 Nobel Prize in Chemistry. Crown ethers are named using the formula x-crown-y, where x is the total number of atoms in the ring and y is the number of ether oxygen atoms. The term 'crown' refers to the crown-like shape that these ether...
5.4K
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.4K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.4K
01:27Nonlinear Pharmacokinetics: Role of Transporters
91
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
91